Exton Michael
SEC insider (Form 3/4/5 filer). CIK 0002029249. Chief Executive Officer at LEXICON PHARMACEUTICALS, INC. (LXRX). 6 reported Form 4/5 transactions since Sep 2024; latest on Feb 28, 2026. Located in THE WOODLANDS, TX.
Companies Exton Michael has filed insider reports for
- LEXICON PHARMACEUTICALS, INC. (LXRX): Director, Officer, Chief Executive Officer
Exton Michael
CIK: 0002029249
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LEXICON PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Feb 28, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect503.3K shares- - Feb 28, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
Tax PaymentDirect204.8K shares at avg. $1.47$301K - Feb 12, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
862.4K shares- - Feb 12, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectStock Option (Right to Buy)
1.3M shares- - Feb 13, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectStock Option (Right to Buy)
2.3M shares- - Feb 13, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
1.5M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 503,263 | - | $0 | Direct |
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Tax Payment | 204,831 | $1.47 | $301,102 | Direct |
| Feb 12, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Restricted Stock Units | 862,440 | - | - | Direct |
| Feb 12, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Stock Option (Right to Buy) | 1,293,670 | - | - | Direct |
| Feb 13, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Stock Option (Right to Buy) | 2,264,690 | - | - | Direct |
| Feb 13, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Restricted Stock Units | 1,509,790 | - | - | Direct |
1-6 of 6 transactions